Results 31 to 40 of about 5,242 (246)

Limitations of the incidence density ratio as approximation of the hazard ratio

open access: yesTrials, 2019
Background Incidence density ratios (IDRs) are frequently used to account for varying follow-up times when comparing the risks of adverse events in two treatment groups.
Ralf Bender, Lars Beckmann
doaj   +1 more source

Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries [PDF]

open access: yes, 2017
Although health technology assessment (HTA) systems base their decision making process either on economic evaluations or comparative clinical benefit assessment, a central aim of recent approaches to value measurement, including value based assessment ...
Angelis, Aris   +2 more
core   +1 more source

Reply to: "Questioning Conclusions and Statements on the German HTA System: A Critical Perspective". [PDF]

open access: yesClin Pharmacol Ther
Clinical Pharmacology &Therapeutics, Volume 117, Issue 1, Page 24-24, January 2025.
Harnett J, Heidt J, Quek RGW, Walsh L.
europepmc   +2 more sources

Q-SEA - a tool for quality assessment of ethics analyses conducted as part of health technology assessments [PDF]

open access: yes, 2017
Introduction: Assessment of ethics issues is an important part of health technology assessments (HTA). However, in terms of existence of quality assessment tools, ethics for HTA is methodologically under-developed in comparison to other areas of HTA ...
Bakke Lysdahl, Kristin   +5 more
core   +3 more sources

Zwischen Konsistenz und Flexibilität

open access: yesMonitor Versorgungsforschung, 2023
Basierend auf den Vorgaben des SGB V bildet Evidenzbasierte Medizin (EbM) die Grundlage für die Arbeit des Gemeinsamen Bundesausschusses (G-BA) sowie des Instituts für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) bei deren medizinischen ...
Hans-Holger Bleß
doaj   +1 more source

HTA und aktuelle Herausforderungen: Harmonisierung, Real World Data und Surrogatparameter

open access: yesGMS Medizinische Informatik, Biometrie und Epidemiologie, 2018
Health Technology Assessment is one of the standard instruments in support of the decision-making to define the public health services both internationally and in the German health care system.
Rüther, Alric   +11 more
doaj   +1 more source

How health technology assessment agencies address the issue of unpublished data [PDF]

open access: yes, 2014
Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG geförderten) Allianz- bzw. Nationallizenz frei zugänglich.This publication is with permission of the rights owner freely accessible due to an Alliance licence and a national licence
Busse, Reinhard   +2 more
core   +1 more source

Study filters for non-randomized studies of interventions consistently lacked sensitivity upon external validation

open access: yesBMC Medical Research Methodology, 2018
Background Little evidence is available on searches for non-randomized studies (NRS) in bibliographic databases within the framework of systematic reviews.
Elke Hausner   +4 more
doaj   +1 more source

Policy Networks and Policy Entrepreneurship in the EU: Explaining Structural Policy Change in Pharmaceutical Innovation Incentives and Health Technology Assessment

open access: yesEuropean Policy Analysis, EarlyView.
ABSTRACT Policy process research has excelled in explaining structural policy change within national settings, but extensions and applications to the EU level have long proven challenging for scholars. Given that the EU is currently experiencing its longest period of Treaty stability since the 1980s—having evolved into a sui generis political system ...
Vassilis Karokis‐Mavrikos
wiley   +1 more source

Home - About - Disclaimer - Privacy